<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Rapamycin on Longetivities</title><link>https://longetivities.com/tags/rapamycin/</link><description>Recent content in Rapamycin on Longetivities</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Thu, 16 Apr 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://longetivities.com/tags/rapamycin/feed.xml" rel="self" type="application/rss+xml"/><item><title>Practical Rapamycin Longevity Protocol</title><link>https://longetivities.com/blog/practical-rapamycin-longevity-protocol/</link><pubDate>Sat, 04 Apr 2026 00:00:00 +0000</pubDate><guid>https://longetivities.com/blog/practical-rapamycin-longevity-protocol/</guid><description>&lt;blockquote&gt;
&lt;p&gt;&lt;strong&gt;Cluster context:&lt;/strong&gt; This article belongs to the &lt;strong&gt;Metabolic and Prescription Longevity Drugs&lt;/strong&gt; cluster. For the broader overview, start with &lt;a href="https://longetivities.com/blog/prescription-longevity-drugs-clinical-guide-to-preventive-medicine/"&gt;Prescription Longevity Drugs: Clinical Guide To Preventive Medicine&lt;/a&gt;.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;p&gt;Rapamycin has become one of the most discussed interventions in longevity research. Originally developed for transplant medicine, this mtor inhibitor has demonstrated consistent life-extending effects in animal models—prompting researchers and clinicians to explore whether similar benefits might translate to human aging.&lt;/p&gt;
&lt;p&gt;The challenge? Moving from promising mouse data to practical human protocols requires careful consideration of dosing, monitoring, and realistic expectations.&lt;/p&gt;</description></item><item><title>Bryan Johnson, Rapamycin, and the Blueprint Protocol: mTOR, Biological Age, and T Cells</title><link>https://longetivities.com/blog/bryan-johnson-rapamycin-and-the-blueprint-protocol-mtor-biological-age-and-t-cel/</link><pubDate>Sat, 21 Mar 2026 00:00:00 +0000</pubDate><guid>https://longetivities.com/blog/bryan-johnson-rapamycin-and-the-blueprint-protocol-mtor-biological-age-and-t-cel/</guid><description>&lt;blockquote&gt;
&lt;p&gt;&lt;strong&gt;Cluster context:&lt;/strong&gt; This article belongs to the &lt;strong&gt;Expert Protocol Profiles&lt;/strong&gt; cluster. For the broader overview, start with &lt;a href="https://longetivities.com/blog/longevity-protocols-2026-practical-evidence-guided-roadmap/"&gt;Longevity Protocols 2026: Practical, Evidence-Guided Roadmap&lt;/a&gt;.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;p&gt;Bryan Johnson&amp;rsquo;s innovative and data-driven health protocol has made him one of the most watched figures in longevity research. His personal commitment to tracking biomarkers and developing the Blueprint protocol—including the decision to incorporate rapamycin and later remove it—offers valuable lessons for anyone interested in anti aging therapies.&lt;/p&gt;</description></item><item><title>How To Get Rapamycin Prescription For Your Longevity Health Journey</title><link>https://longetivities.com/blog/how-to-get-rapamycin-prescription-for-your-longevity-health-journey/</link><pubDate>Sun, 25 Jan 2026 00:00:00 +0000</pubDate><guid>https://longetivities.com/blog/how-to-get-rapamycin-prescription-for-your-longevity-health-journey/</guid><description>&lt;blockquote&gt;
&lt;p&gt;&lt;strong&gt;Cluster context:&lt;/strong&gt; This article belongs to the &lt;strong&gt;Metabolic and Prescription Longevity Drugs&lt;/strong&gt; cluster. For the broader overview, start with &lt;a href="https://longetivities.com/blog/prescription-longevity-drugs-clinical-guide-to-preventive-medicine/"&gt;Prescription Longevity Drugs: Clinical Guide To Preventive Medicine&lt;/a&gt;.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;p&gt;Rapamycin has emerged as one of the most discussed compounds in longevity medicine, with studies showing 9-14% lifespan extension in mice and promising early data in humans. Originally FDA approved for preventing organ transplant rejection, this medication has gained traction among those seeking to delay age related diseases and extend their healthspan.&lt;/p&gt;</description></item></channel></rss>